Plain-English plan summary
According to public Form 5500 filings published through the U.S. Department of Labor (DOL) Employee Benefits Security Administration (EBSA) via the EFAST2 system, Acadia Pharmaceuticals 401(K) Plan And Trust is a benefit plan reported by Acadia Pharmaceuticals, Inc. under EIN 06-1376651 and plan number 001. The latest loaded filing year is 2023. The filing reports 788 participants and $116,588,844 in end-of-year plan assets, where available in the loaded dataset.
Reported financial statement (2023 · Schedule H)
Net assets
- Total assets (EOY)
- $116,588,844
- Total liabilities (EOY)
- $0
- Net assets (EOY)
- $116,588,844
- Net assets (BOY)
- $92,728,005
Income & contributions
- Employer contributions
- $6,076,057
- Participant contributions
- $10,579,491
- Total contributions
- $18,727,930
- Total income / additions
- $37,073,590
Expenses & distributions
- Benefits paid
- $13,277,338
- Administrative expenses
- -$64,587
- Total expenses
- $13,212,751
- Net increase / (decrease)
- $23,860,839